1. Rabeharisoa V. The struggle against neuromuscular diseases in France and the emergence of the “partnership model” of patient organization. Soc Sci Med. 2003;57:2127–36.
2. Terry SF. Learning Genetics. Health Aff. 2003;22(5):166–71.
3. International Rare Diseases Research Consortium. Policies & Guidelines. 2013.
http://www.irdirc.org/wp-content/uploads/2013/06/IRDiRC_policies_24MayApr2013.pdf
. Accessed 08 Dec 2016 Dec 08.
4. Wehling P, Viehöver W, Koenen S. Patient associations, health social movements and the public shaping of biomedical research: an introduction. In: Wehling P, Viehöver W, Koenen S, editors. The public shaping of medical research: patient associations, health movements and biomedicine. London: Routledge; 2015. p. 1–20.
5. Asbury CH. Orphan Drugs: Medical versus Market Value. D.C. Health and Company: Lexington; 1985.